Published in Vaccine Weekly, June 28th, 1999
A cover-story article published in the June 1, 1999, issue of the Journal of Neurosurgery describes the findings, expected to serve as a basis for future clinical trials in humans.
Dr. Linda Liau, UCLA's Jonsson Cancer Center, and first author of the article, led the investigation of the vaccine. The vaccine uses powerful immune cells called dendritic cells to stimulate the immune system to attack malignant gliomas, the most fatal type of cancerous brain tumor.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.